You are required to be logged in to access the full website
Click here if you have forgotten your username or password
28 March 2024 - US-based screening and early detection specialist Polymedco LLC announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for the PATHFAST high-sensitivity cardiac troponin I (hs-cTnI-II) test as an ai...
28 March 2024 - Kintara Therapeutics, Inc. (Nasdaq: KTRA), a California-based biopharmaceutical company, announced on Wednesday that it has expanded the inclusion criteria in the open label 15-patient REM-001 study in cutaneous metastatic breast canc...
28 March 2024 - Virion Therapeutics LLC, a US-based clinical-stage biotechnology company, announced on Wednesday initial safety data from the first-ever human data from its novel, first-in-class, checkpoint modifier immunotherapy, VRON-0200, for HBV ...
28 March 2024 - US biopharmaceutical company Akebia Therapeutics Inc (Nasdaq: AKBA) announced on Wednesday that it has received approval from the US Food and Drug Administration (FDA) for Vafseo (vadadustat) Tablets for the treatment of anaemia due t...
28 March 2024 - VGXI Inc, a Texas-based contract developer and manufacturer (CDMO) specialising in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines and RNA medicines, announced on Wednesday the appointment of Stephanie Burke as...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe